rs116900568

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001283009.2(RTEL1):​c.1761G>A​(p.Pro587Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00353 in 1,610,322 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P587P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0033 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0036 ( 28 hom. )

Consequence

RTEL1
NM_001283009.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -3.93

Publications

3 publications found
Variant links:
Genes affected
RTEL1 (HGNC:15888): (regulator of telomere elongation helicase 1) This gene encodes a DNA helicase which functions in the stability, protection and elongation of telomeres and interacts with proteins in the shelterin complex known to protect telomeres during DNA replication. Mutations in this gene have been associated with dyskeratosis congenita and Hoyerall-Hreidarsson syndrome. Read-through transcription of this gene into the neighboring downstream gene, which encodes tumor necrosis factor receptor superfamily, member 6b, generates a non-coding transcript. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2013]
RTEL1-TNFRSF6B (HGNC:44095): (RTEL1-TNFRSF6B readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring RTEL1 (regulator of telomere elongation helicase 1) and TNFRSF6B (tumor necrosis factor receptor superfamily, member 6b, decoy) genes on chromosome 20. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is unlikely to produce a protein product. [provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 20-63688566-G-A is Benign according to our data. Variant chr20-63688566-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 436567.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.93 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00333 (507/152334) while in subpopulation AMR AF = 0.00438 (67/15312). AF 95% confidence interval is 0.00385. There are 3 homozygotes in GnomAd4. There are 230 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AD,SD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001283009.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RTEL1
NM_001283009.2
MANE Select
c.1761G>Ap.Pro587Pro
synonymous
Exon 21 of 35NP_001269938.1Q9NZ71-6
RTEL1
NM_032957.5
c.1833G>Ap.Pro611Pro
synonymous
Exon 21 of 35NP_116575.3Q9NZ71-7
RTEL1
NM_016434.4
c.1761G>Ap.Pro587Pro
synonymous
Exon 21 of 35NP_057518.1Q9NZ71-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RTEL1
ENST00000360203.11
TSL:5 MANE Select
c.1761G>Ap.Pro587Pro
synonymous
Exon 21 of 35ENSP00000353332.5Q9NZ71-6
RTEL1
ENST00000508582.7
TSL:2
c.1833G>Ap.Pro611Pro
synonymous
Exon 21 of 35ENSP00000424307.2Q9NZ71-7
RTEL1
ENST00000370018.7
TSL:1
c.1761G>Ap.Pro587Pro
synonymous
Exon 21 of 35ENSP00000359035.3Q9NZ71-1

Frequencies

GnomAD3 genomes
AF:
0.00334
AC:
509
AN:
152216
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000772
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00438
Gnomad ASJ
AF:
0.0222
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00372
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.00426
Gnomad OTH
AF:
0.00621
GnomAD2 exomes
AF:
0.00367
AC:
895
AN:
244144
AF XY:
0.00382
show subpopulations
Gnomad AFR exome
AF:
0.000579
Gnomad AMR exome
AF:
0.00234
Gnomad ASJ exome
AF:
0.0211
Gnomad EAS exome
AF:
0.0000549
Gnomad FIN exome
AF:
0.000148
Gnomad NFE exome
AF:
0.00439
Gnomad OTH exome
AF:
0.00521
GnomAD4 exome
AF:
0.00355
AC:
5183
AN:
1457988
Hom.:
28
Cov.:
33
AF XY:
0.00359
AC XY:
2603
AN XY:
725264
show subpopulations
African (AFR)
AF:
0.000717
AC:
24
AN:
33456
American (AMR)
AF:
0.00290
AC:
129
AN:
44524
Ashkenazi Jewish (ASJ)
AF:
0.0205
AC:
533
AN:
26040
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39664
South Asian (SAS)
AF:
0.00232
AC:
199
AN:
85892
European-Finnish (FIN)
AF:
0.000233
AC:
12
AN:
51404
Middle Eastern (MID)
AF:
0.0204
AC:
109
AN:
5346
European-Non Finnish (NFE)
AF:
0.00350
AC:
3888
AN:
1111400
Other (OTH)
AF:
0.00478
AC:
288
AN:
60262
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
282
565
847
1130
1412
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
144
288
432
576
720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00333
AC:
507
AN:
152334
Hom.:
3
Cov.:
33
AF XY:
0.00309
AC XY:
230
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.000770
AC:
32
AN:
41582
American (AMR)
AF:
0.00438
AC:
67
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.0222
AC:
77
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00373
AC:
18
AN:
4830
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10620
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.00425
AC:
289
AN:
68028
Other (OTH)
AF:
0.00568
AC:
12
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
26
52
78
104
130
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00459
Hom.:
1
Bravo
AF:
0.00309
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not provided (6)
-
-
2
not specified (2)
-
-
1
Dyskeratosis congenita (1)
-
-
1
Dyskeratosis congenita, autosomal recessive 5 (1)
-
-
1
Dyskeratosis congenita, autosomal recessive 5;C4225346:Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
3.4
DANN
Benign
0.91
PhyloP100
-3.9
PromoterAI
-0.0052
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116900568; hg19: chr20-62319919; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.